An open clinical trial of venlafaxine treatment of fibromyalgia

Psychosomatics

Volumn 39, Issue 1, 1998, Pages 14-17

  Dwight, Megan M ^a   Arnold, Lesley M ^a,b   O'Brien, Hadley ^a   Metzger, Ray ^a   Morris Park, Emily ^a   Keck Jr , Paul E ^a  

^a UNIVERSITY OF CINCINNATI   (United States)

^b UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; CHLORAL HYDRATE; DIPHENHYDRAMINE; VENLAFAXINE;

ADULT; ANXIETY NEUROSIS; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; COMORBIDITY; CONSTIPATION; DEPRESSION; DRUG RESPONSE; FATIGUE; FEMALE; FIBROMYALGIA; HEADACHE; HUMAN; INSOMNIA; MALE; NAUSEA; XEROSTOMIA;

EID: 0031946836     PISSN: 00333182     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0033-3182(98)71375-1     Document Type: Article

References (19)

1. Wolfe F, Ross K, Anderson J, et al: The prevalence and characteristics of fibromyalgia in the general population. Arthritis Rheum 1995; 38:19-27
2. Goldenberg DL, Simmus RW, Geiger A, et al: High frequency of fibromyalgia patients with chronic fatigue seen in a primary care practice. Arthritis Rheum 1990; 33:381-387
3. Skootsky SA, Jaeger B, Oye RD: Prevalence of myofascial pain in general internal medicine practice. West J Med 1989; 151:157-160
4. Wolfe F, Cathey M: Prevalence of primary and secondary fibrositis. J Rheumatol 1983; 26:817-825
5. Scudds RA, McCain GA, Rollman GB, et al: Improvements in pain responsiveness in patients with fibrositis after successful treatment with amitriptyline. J Rheumatol 1989; 16(suppl):S98-S103
6. Goldenberg DL, Felson DT, Dinerman H: A randomized controlled trial of amitriptyline and naproxen in the treatment of patients with fibromyalgia. Arthritis Rheum 1986; 29:1371-1377
7. Carrette S, McCain GA, Bell DA, et al: Evaluation of amitriptyline in primary fibrositis: a double-blind, placebo controlled study. Arthritis Rheum 1986; 29:655-659
8. Carrette S, Bell MJ, Reynolds WJ, et al: Comparison of amitriptyline, cyclobenzaprine, and placebo in the treatment of fibromyalgia: a randomized, double-blind clinical trial. Arthritis Rheum 1994; 37:32-40
9. Preskorn SH: Antidepressant drug selection: criteria and options. J Clin Psychiatry 1994; 55:6-22
10. First MB, Spitzer RL, Gibbon M, et al: Structured Clinical Interview for the DSM-IV Axis I Disorders-patient edition (SCID-I/P, version 2.0). New York, Biometrics Research Department, New York State Psychiatric Institute, 1995
11. Pope HG Jr, Hudson JI: A supplemental interview for forms of "affective spectrum disorder." Int J Psychiatry Med 1991; 21:202-232
12. Hamilton M: A rating scale for depression. J Neurol Neurosurg Psychiatry 1960; 23:56-62
13. Hamilton M: The assessment of anxiety disorders by rating. Br J Med Psychol 1959; 32:50-65
14. Melzack R: The McGill Pain Questionnaire: major properties and scoring methods. Pain 1975; 1:277-299
15. Derogatis LR: The Psychosocial Adjustment to Illness Scale self-report version. Baltimore, MD, Clinical Psychometric Research, 1990
16. Hudson JI, Pope HG: Fibromyalgia and psychopathology: is fibromyalgia a form of "affective spectrum disorder?" J Rheumatol 1989; 16(suppl 19):S15-S22
17. Hudson JI, Goldenberg DL, Pope HI, et al: Comorbidity of fibromyalgia with medical and psychiatric disorders. Am J Med 1992; 92:363-367
18. Cantini F, Bellandi F, Niccoli L, et al: Fluoxetine combined with cyclobenzaprine in the treatment of fibromyalgia (abstract). Minerva Med 1994; 85:97-100
19. Goldenberg DL, Mayskiy M, Mossey C, et al: A randomized, double-blind crossover trial of fluoxetine and amitriptyline in the treatment of fibromyalgia. Arthritis Rheum 1996; 39:1852-1859